santa cruz biotechnology, inc.

| |
|
| | MLCK Inhibitors
- ML-9
A naphthalenesulfonamide derivative selective inhibitor of MLCK that acts by delaying MLCK phosphorylation through binding at or near the ATP binding site.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200519 | 105637-50-1 | C15H17N2O2SCl•HCl | 10 mg/50 mg |
|